Fundraising Fox

Osteal Therapeutics

Dallas, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

BD
Brian de BeaubienExecutive Officer, Director
DT
David ThompsonExecutive Officer, Director
RR
Renee RyanDirector
JP
Jude PaganelliExecutive Officer, Director
MS
Martin SandsDirector
JC
Judson CooperDirector
BM
Biren MehtaDirector
DC
David CashDirector
RL
Rushu LuoDirector
EO
Erik OrosDirector
SP
Sonal PatelDirector
DK
Douglas KohrsDirector

Investors · 1

HM Venture PartnersSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$15.6MraisedNov 2025 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin SandsDirector
  • Judson CooperDirector
  • Brian de BeaubienExecutive Officer, Director
  • David ThompsonExecutive Officer, Director
  • Biren MehtaDirector
  • Douglas KohrsDirector
  • David CashDirector
  • Rushu LuoDirector
  • Erik OrosDirector
  • Sonal PatelDirector
Offering amount
$26.7M
Amount sold
$15.6M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedJun 2024 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Biren MehtaDirector
  • Rushu LuoDirector
  • David CashDirector
  • David ThompsonExecutive Officer, Director
  • Sonal PatelDirector
  • Brian de BeaubienDirector
  • Martin SandsDirector
  • Judson CooperDirector
  • Douglas KohrsDirector
Offering amount
$50M
Amount sold
$50M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.3MraisedSep 2023 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin SandsDirector
  • Judson CooperDirector
  • David CashDirector
  • Biren MehtaDirector
  • David ThompsonExecutive Officer, Director
  • Rushu LuoDirector
  • Brian de BeaubienDirector
  • Douglas KohrsDirector
Offering amount
$23M
Amount sold
$22.3M
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.2MraisedDec 2021 · 59 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas KohrsDirector
  • David CashDirector
  • Brian de BeaubienDirector
  • David ThompsonExecutive Officer, Director
  • Judson CooperDirector
  • Noam KrantzDirector
  • Rushu LuoDirector
Offering amount
$32.4M
Amount sold
$30.2M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJan 2021 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Noam KrantzDirector
  • Jude PaganelliExecutive Officer, Director
  • David CashDirector
  • Brian de BeaubienDirector
  • Douglas KohrsDirector
  • David ThompsonExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.4MraisedApr 2018 · 45 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas KohrsDirector
  • Brian de BeaubienDirector
  • Renee RyanDirector
  • Jude PaganelliExecutive Officer, Director
Offering amount
$7.8M
Amount sold
$7.4M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.